DailyMed is the primary source of medicine documentation for patients and doctors in the USA. It contains documents more or less equivalent to UK Summary of Product Characteristics (SPC or SmPC) and Patient Information Leaflets (PIL).
DailyMed
dailymed.nlm.nih.gov/dailymed/
The USA has also relatively recently launched the Inactive Ingredients Database (IID) and assigned UNII (Unique Ingredient Identifier) codes to a large number of excipients.
IID Search
accessdata.fda.gov/scripts/...
This puts their public information way ahead of what is available in the UK.
Yet this paper reports "internal inconsistencies of excipients in 39% of the formulations examined". Despite these strides forward.
And the MHRA doesn't even seem to care whether manufacturers include E-number codes against excipients to which E-numbers have been assigned. Despite doing so being of potential help to patients, in particular, who might already know they must avoid certain E-numbers in their diets but have to go round the houses to check whether the names in PILs are the same substances.
Patients simply do not have the required information and tools. But, in general, doctors do not have the understanding, information, tools, or time, to handle these issues. Nor do pharmacists. If the information isn't available in some form of database, no-one can reasonably be expected to find it. Even when there is a decent supply of inclination.
Inconsistent excipient listings in DailyMed: implications for drug safety.
Kinsella L 1 , Brook J 2 , Briest M 3 , Brook MJ 4
Naunyn-schmiedeberg's Archives of Pharmacology, 02 Apr 2024, 397(9):6851-6854
doi.org/10.1007/s00210-024-... PMID: 38563879
Abstract
Excipients, or inactive ingredients, are a frequent cause of medication intolerance and allergy. Patients and clinicians concerned about medication allergies and sensitivities rely on the U.S. National Library of Medicine's DailyMed for accurate lists of excipients. Based on our anecdotal discovery of several examples of excipient omissions, we wished to examine the accuracy of DailyMed's listings more systematically in a sample of commonly prescribed medications. The objective of the study is to identify the frequency of inconsistency of excipient reporting within the DailyMed website. We performed a database audit of the Structured Product Labeling XML file provided by the drug manufacturer to the Food and Drug Administration and DailyMed for two randomly selected formulations of each of 50 commonly prescribed medications. For each of the 100 formulations, we compared the excipients listed in the "Description" to those in the "Ingredients and Appearance" sections in DailyMed. The Structured Product Labeling data file provided by the drug manufacturer contained internal inconsistencies of excipients in 39% of the formulations examined. Despite the use of Structured Product Labeling, the drug manufacturer's medication labels provided to the FDA and reported by DailyMed often contain conflicting information about inactive ingredients. Patients with allergies and excipient sensitivity should be aware of these discrepancies and consult multiple sections of the label to identify potential allergy-inducing inactive ingredients.
As so often, the full paper is behind a paywall.